// App-Quantinova.ai

4215 : Outcomes of Adults with Acute Lymphoblastic Leukemia (ALL) Following Relapse After First Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Researchers

Presenter

  • LM Poon

Principal Investigators

  • Rima M. Saliba

  • Stefan O. Ciurea

  • Elizabeth J. Shpall

  • Richard E. Champlin

  • Partow Kebriaei

  • Gabriela Rondon

  • Celina Ledesma

  • Muzaffar Qazilbash

  • Chitra M. Hosing

  • Roy B. Jones

  • Uday R. Popat

  • Nieto

  • Amin M. Alousi

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Interleukin 1 alpha

Drug/Treatment

  • Clofarabine

  • Vincristine

  • Nelarabine

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved